Where does Xcella Biosciences, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Xcella Biosciences, Inc. ranks #27,847 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Xcella Biosciences, Inc. hold?

Xcella Biosciences, Inc. holds 10 US utility patents granted between 2018 and 2025, spanning 8 technology areas.

What is Xcella Biosciences, Inc.'s Innovation Score?

Xcella Biosciences, Inc. has an Innovation Score of 41.9 out of 100 (top 32% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Xcella Biosciences, Inc. focus on?

Xcella Biosciences, Inc.'s top technology area is G01N (Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties) with 10 patents, ranking #1,460 of 7,863 assignees active in that subclass. Grants appear in 8 CPC subclasses total.

Is Xcella Biosciences, Inc.'s patent grant rate increasing or decreasing?

Xcella Biosciences, Inc.'s recent grant velocity is +200% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for Xcella Biosciences, Inc.'s patents?

Xcella Biosciences, Inc.'s patents average 24.5 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Xcella Biosciences, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Xcella Biosciences, Inc.

USPTO PatentsView assignee record - 10 granted patents across 8 technology areas, recorded in grant years 2018–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: G01N (Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Xcella ranks #27,847 of 49,997 tracked US assignees by granted-patent volume, with 10 patents across 8 technology areas.

#27,847
of 49,997 US assignees by volume: Top 32%
by Innovation Score (41.9/100): 24.5
avg claims per patent: +200%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R27847 · US Corporation #27,847 · 10 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-DENSE · TYPE-USCORP · VEL-SURGE · BOOK-FULL

GRANTS-MICRO 10 grants
MID-PACK #27,847/49,997
PHOTO-FINISH Wooshin Safety Systems
CPC-NARROW G01N · 8 areas
INNOV-PAR 41.9/100
CLAIMS-DENSE 24.5 claims/avg
TYPE-USCORP US Corporation
VEL-SURGE +200% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Wooshin Safety Systems Co., Ltd. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Xcella’s 41.9 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 8.3 pts (20%) Velocity 8.9 pts (21%) Breadth 10.0 pts (24%) Claim depth 14.7 pts (35%)

Qualcomm Incorporated · highest

85
Xcella Biosciences · this assignee

42
3D Lighting… · lowest

7

What this shows Xcella's Innovation Score is 41.9/100 (top 32% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Xcella?

Each dot is one of Xcella’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Xcella’s own 24.5 claims/patent is ABOVE the 14.0 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Xcella vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Xcella's grants concentrate

Xcella Biosciences, Inc. is a focused PatentsView assignee: 8 CPC subclasses with 100% of grants classified under G01N (Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties). Peak complete grant year is 2021 (2 grants) versus a trough of 1 in 2018. By volume, Xcella sits between Wooshin Safety Systems Co., Ltd. and Xiamen Ghgm Electric Co., Ltd.

Xcella's three-year grant acceleration

Xcella Biosciences, Inc. shows 4 grants in 2022–2024 against only 3 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Wooshin Safety Sy…

10
Wostec

10
Wrightspeed

10
X-therma

10
Xenon

10
XG Sciences

10
Xi'an Modern Chem…

10
Xiamen Ghgm Elect…

10
Xcella Biosciences ◀

10

What this shows Xcella holds 10 patents at rank #27,831, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Xcella

By rank, the assignees closest to #27,831 in granted patent volume.

Leaders in G01N (Investigating OR Analysing Materials BY Determining Their…)

Other assignees with the most granted patents in Xcella's primary technology class.

Xcella's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

42 Top 32% higher than 68% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2018–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2018–2019 baseline. Full figures in the table below.

View data table

Xcella Biosciences, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2018	1	10.0%
2019	1	10.0%
2021	2	20.0%
2022	2	20.0%
2023	1	10.0%
2024	1	10.0%
2025partial year	2	20.0%

Which technologies does Xcella Biosciences, Inc. patent most?

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 10

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 8

B01L - Chemical OR Physical Laboratory Apparatus FOR General USE 7

C40B - Combinatorial CHEMISTRY; Libraries, e.g. Chemical Libraries 4

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 4

C12M - Apparatus FOR Enzymology OR MICROBIOLOGY; Apparatus FOR Culturing Microorganisms FOR Producing Biomass, FOR Growing Cells OR FOR Obtaining Fermentation OR Metabolic Products, i.e. Bioreactors OR Fermenters 2

B01J - Chemical OR Physical Processes, e.g. Catalysis OR Colloid CHEMISTRY; Their Relevant Apparatus 2

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 1

Top 8 of 8 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Xcella Biosciences, Inc.'s patent record in context - here's where to go next.

Xcella Biosciences, Inc.'s lead technology class is G01N (Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties), 100% of its portfolio - see every assignee active in that class. Explore G01N
Ranked #27,847 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Xcella Biosciences, Inc. against Wooshin Safety Systems Co., Ltd., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 41.9/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.